TITLE

Langfristige Ergebnisse nach Synovektomien am oberen Sprunggelenk des Rheumatikers

AUTHOR(S)
S. Anders; J. Schaumburger; S. Kerl; S. Schill; J. Grifka
PUB. DATE
November 2007
SOURCE
Zeitschrift für Rheumatologie;Nov2007, Vol. 66 Issue 7, p595
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Zusammenfassung  Entz�ndlich rheumatische Ver�nderungen am R�ckfu� des Rheumatikers gef�hrden dessen Mobilit�t durch Schmerz und Funktionsverlust. In unserem Patientengut erfolgte bei 29 Patienten nach 14,3 Jahren Rheumatoide-Arthritis- (RA-)Dauer und durchschnittlich 7,6 Jahre nach lokaler Manifestation eine Synovektomie des oberen Sprunggelenks (OSG) mit fakultativer Begleittenosynovektomie. Erkrankungsdauer und das Vorherrschen definitiver radiologischer Ver�nderungen (81% Larsen, Dale, Eek/LDE 2–3) charakterisieren die durchgef�hrten Eingriffe als Sp�tsynovektomien. Der hohe Anteil an Begleittenosynovektomien (93%) sowie die hohe Inzidenz radiologischer Ver�nderungen der Anschlussgelenke des R�ckfu�es (Kalkaneokuboidalgelenk/CC-Gelenk, Talonavikulargelenk/TN-Gelenk, unteres Sprunggelenk/USG) deuten auf eine gelenk�bergreifende Pathologie durch die RA hin. Eine radiologische Progression der LDE-Klasse fand sich bei 62% der Gelenke. Der signifikante Anstieg des Kofoed-Scores von 42,4 auf 55,9 Punkte (p=0,042) war ma�geblich durch die Schmerzreduktion und geringer auch durch einen Funktionszuwachs begr�ndet, w�hrend bei der Rubrik Mobilit�t Einbu�en zu verzeichnen waren. Die durchschnittliche Schmerzintensit�t auf der visuellen Analogskala (VAS) sank signifikant von 7,6 auf 3,3 (p
ACCESSION #
27683024

 

Related Articles

  • Consortium launches study to search for rheumatoid... Sweeney, Rosemarie; Rose, Verna L. // American Family Physician;11/1/1997, Vol. 56 Issue 7, p1706 

    Deals with the national consortium of 12 research centers in the search for genes that determine the susceptibility to rheumatoid arthritis. Organizations that supported the national consortium.

  • ARTHRITIS RELIEF.  // Prevention;Oct89, Vol. 41 Issue 10, p8 

    Reports on the findings of a study that joint damage caused by rheumatoid arthritis can be prevented if it is treated right and early. Comparison of the effects of hydroxychloroquine and sulfasalazine on the progression of joint damage; Prescription of aspirin and other non-steroidal...

  • Rheumatology: 5. Diagnosis and management of inflammatory polyarthritis. Klinkhoff, Alice // CMAJ: Canadian Medical Association Journal;6/27/2000, Vol. 162 Issue 13, p1833 

    Reports on the management of inflammatory polyarthritis. Diagnostic criteria and differential diagnosis; Useful laboratory tests for patients with recent onset of inflammatory polyarthritis; Effectiveness of disease-modifying antirheumatic drugs (DMARDs); Other conditions that should be ruled...

  • COMMENTARY: Review: Anti-tumor necrosis factor antibody therapy for rheumatoid arthritis increases risk for serious infection and malignancy. Shoor, Stanford // ACP Journal Club;Nov/Dec2006, Vol. 145 Issue 3, p65 

    The article presents the author's comments on a medical study on anti-tumor necrosis factor (anti-TNF) antibody therapy for rheumatoid arthritis. The study revealed that the antibody therapy for rheumatoid arthritis increases risk for serious infection and malignancy. But the author says that...

  • Hydroxychloroquine is Associated with Less Diabetes in RA.  // Clinical Oncology Alert;Sep2007 Supplement, Vol. 12 Issue 9, p17 

    The article discusses research being done on the incidence of new onset diabetes in rheumatoid arthritis patients treated with hydroxychloroquine (HCQ). It references a study by M. C. M. Wasko et al published in the 2007 issue of the "Journal of American Medical Association." Longer HCQ use was...

  • RA bone loss.  // GP: General Practitioner;5/26/2006, p14 

    The article reports on a British medical study conducted on 74 patients with undifferentiated hand arthritis. The study showed that hand bone loss over 12 months was five to eight times greater in patients who were diagnosed with rheumatoid arthritis, than in those with other inflammatory joint...

  • Adaptation of the RAQoL for use in Australia. Cox, S.; McWilliams, L.; Massy-Westropp, N.; Meads, D.; McKenna, S.; Proudman, S. // Rheumatology International;May2007, Vol. 27 Issue 7, p661 

    Quality of life is an important patient-reported outcome of rheumatoid arthritis (RA) in addition to structural and functional outcomes. The RAQoL (Rheumatoid Arthritis Quality of Life questionnaire) was developed in the UK and the Netherlands as a disease-specific tool. It was adapted for use...

  • The expression of chemokine receptor CXCR3: relevance to disease activity of rheumatoid arthritis. Motoki, Yumi; Tani, Kenji; Shimizu, Teruki; Tamiya, Hiroyuki; Hase, Kayoko; Ohmoto, Yasukazu; Matsushima, Kouji; Sone, Saburo // Modern Rheumatology (Springer Science & Business Media B.V.);Jun2003, Vol. 13 Issue 2, p114 

    CXC chemokine receptor 3 (CXCR3) is selectively expressed on T helper 1 (Th1) type T cells and has been shown to be responsible for Th1-dominant immune responses. In this study, we analyzed the expression of CXCR3 on peripheral blood T lymphocytes of patients with rheumatoid arthritis (RA) by...

  • Gene research partnership launched. Goldberg, Carol // Long Island Business News (7/1993 to 5/2009);09/22/97, Vol. 44 Issue 38, p34 

    Reports on the plan of a consortium of 12 research centers, led by the North Shore University Hospital, for a five-year search for genes that determine susceptibility to rheumatoid arthritis (RA). Background on RA; Existing body of knowledge on the genetic factors in RA; Role of the North...

  • Combined Structural and Synovial Assessment for Improved Ultrasound Discrimination of Rheumatoid, Osteoarthritic, and Normal Joints: A Pilot Study. Kunkel, Gary A.; Cannon, Grant W.; Clegg, Daniel O. // Open Rheumatology Journal;2012, Vol. 6, p199 

    Background: Current ultrasonographic scoring systems used to assess the degree of finger joint synovitis in rheumatoid arthritis (RA) are not designed for distinguishing healthy or osteoarthritis (OA) patients from those with RA in clinical settings. Objective: To explore a novel scoring...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics